CN Patent

CN109232582B — 拉洛替尼硫酸氢盐晶型及其制备和应用

Assigned to Jiangsu Acebright Pharmaceutical Co ltd · Expires 2021-02-05 · 5y expired

What this patent protects

本发明涉及拉洛替尼硫酸氢盐晶型及其制备和应用。具体地，本发明公开了拉洛替尼硫酸氢盐晶型，所述晶型具有优异的溶解性能、机械稳定性能和高湿稳定性。

USPTO Abstract

本发明涉及拉洛替尼硫酸氢盐晶型及其制备和应用。具体地，本发明公开了拉洛替尼硫酸氢盐晶型，所述晶型具有优异的溶解性能、机械稳定性能和高湿稳定性。

Drugs covered by this patent

larotrectinib-sulfate (LAROTRECTINIB SULFATE)

Patent Metadata

Patent number: CN109232582B
Jurisdiction: CN
Classification: —
Expires: 2021-02-05
Drug substance claim: No
Drug product claim: No
Assignee: Jiangsu Acebright Pharmaceutical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.